Development of a highly efficient purification process for recombinant adenoviral vectors for oral gene delivery

Pharmaceutical Development and Technology

Volumn 3, Issue 3, 1998, Pages 365-372

  Croyle, Maria A ^a,c   Anderson, Douglas J ^a   Roessler, Blake J ^a,b   Amidon, Gordon L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adenovirus; Lyophilization; Sucrose gradient; Ultracentrifugation; Viral purification

Indexed keywords

VIRUS VACCINE; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; EXPRESSION VECTOR; FREEZE DRYING; GENE TARGETING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SUCROSE GRADIENT; ULTRACENTRIFUGATION; VIRUS RECOMBINANT;

EID: 0031711076     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.3109/10837459809009864     Document Type: Article

References (25)

1. W. R. Smythe, H. C. Hwang, A. A. Elshami, K. M. Amin, S. M. Albelda, and L. R. Kaiser, Differential sensitivity of thoracic malignant tumors to adenovirus-mediated drug sensitization gene therapy, J. Thorac. Cardiovas. Surg., 109(4), 626-6631 (1995).
2. P. Tolstoshev, Gene therapy, concepts, current trials and future directions, Annu. Rev. Pharmacol. Toxicol., 32, 573-96 (1993).
3. K. F. Kozarsky, K. Jooss, M. Donahee, J. F. I. Strauss, and J. M. Wilson, Effective treatment of familial hypercholesterolemia in the mouse model using adenovirusmediated gene transfer of the vldl receptor gene, Nat. Genet, 13(1), 54-62 (1996).
4. T. Ragot, L. D. Stratford-Perricaudet, N. Vincent, P. Chafey, E. Vigne, H. Gilgenkrantz, D. Couton, P. Briand, K. C. Kaplan, A. Kahn, et al., Adenovirus-mediated transfer of a human dystrophan gene to skeletal muscle of mdx mouse, Gene Ther., 1(suppl. 1), S53-S54 (1994).
5. B. L. Davidson, S. E. Doran, D. S. Shewach, J. M. Latta, J. W. Hartman, and B. J. Roessler, Expression of Escherichia coli β-galactosidase and rat HPRT in the CNS of Macaca mulatto following adenoviral mediated gene transfer, Exp. Neurol., 125(2), 258-267 (1994).
6. J. F. Engelhardt, Y. Yang, L. D. Stratford-Perricaudet, E. D. Allen, K. Kozarsky, M. Perricaudet, J. R. Yankaskas, and J. M. Wilson, Direct gene transfer of human cftr into human bronchial epithelia of xenografts with el-deleted adenoviruses, Nat. Genet., 4, 27-34 (1993).
7. G. Bellon, L. Michel-Calemard, D. Thouvenot, V. Jagneaux, F. Poitevin, C. Malcus, et al., Aerosol administration of a recombinant adenovirus expressing cftr to cystic fibrosis patients: A phase I clinical trial, Human Gene Ther., 8(1), 15-25 (1997).
8. S. L. Eck, J. B. Alavi, A. Davis, D. Hackney, K. Judy, J. Mollman, P. C. Phillips, E. B. Wheeldon, and J. M. Wilson, Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: A phase I trial, Human Gene Ther., 7(12), 1465-82 (1996).
9. T. Tursz, A. L. Cesne, P. Baldeyrou, E. Gautier, P. Opolon, C. Schatz, A. Pavirani, M. Courtney, D. Lamy, T. Ragot, P. Saulnier, A. Andremont, R. Monier, M. Perricaudet, and T. Le Chavalier, Phase I study of recombinant adenovirus-mediated gene transfer in lung cancer patients, J. Nat. Cancer Instit., 88(24), 1857-63 (1996).
10. M. Green and M. Pina, Biochemical studies on adenovirus multiplication. IV. Isolation, purification, and chemical analysis of adenoviruses, Virology, 20, 199-207 (1963).
11. W. D. Winters and W. C. Russell, Studies on the assembly of adenovirus in vitro, J. Gen. Virol., 10, 181-194 (1971).
12. F. L. Graham, J. Smiley, W. C. Russell, and R. Nairn, Characteristics of a human cell line transformed by DNA from human adenovirus type 5, J. Gen. Virol., 36, 59-74 (1977).
13. F. L. Graham, and A. J. van der Eb, A new technique for the assay of infectivity of human adenovirus 5 DNA, Virology, 52, 456-467 (1973).
14. J. H. Miller, Behavior of mutants on indicator plates, in Experiments in Molecular Genetics, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1972, p. 48.
15. U. K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680-685 (1970).
16. 32P labeling and purification of adenovirus 5 by sucrose density gradient, Ann. Inst. Pasteur Lille, 16, 103-110 (1965).
17. P. D. Parkman and M. C. Hardegree, Regulation and testing of vaccines, in Vaccines (S. A. Plotkin and E. A. Mortimer, eds.), W. B. Saunders Co., Philadelphia, 1994, pp. 889-901.
18. M. A. Croyle, B. L. Davidson, B. J. Roessler, and G. L. Amidon, Pharmaceutical stabilization of adenoviral vectors, Proc. Int. Symp. Controlled Release Bioact. Mater., 1, 1433-1434 (1994).
19. R. M. McCombs and W. E. Rawls, Density gradient centrifugation of rubella virus, J. Virol., 2(5), 409-414 (1968).
20. A. R. Neurath, T. J. Wiktor, and H. Koprowski, Density gradient centrifugation studies on rabies virus, J. Bacteriol., 92(1), 102-106 (1966).
21. R. N. Perham, Sucrose density-gradient analysis of the alkaline degradation of tobacco mosaic virus, J. Molec. Biol., 45, 439-441 (1969).
22. D. Pieniazek, N. J. Pieniazek, D. Macejak, J. Coward, M. Rayfield, and R. B. Luftig, Differential growth of human enteric adenovirus 41 (TAK) in continuous cell lines, Virology, 174, 239-249 (1990).
23. D. M. Perron-Henry, J. E. Herrmann, and N. R. Blacklow, Isolation and propagation of enteric adenoviruses in HEp-2 cells, J. Clin. Microbiol., 26(8), 1445-1447 (1988).
24. J. Vinograd, Sedimentation equilibrium in a buoyant density gradient. Meth. Enzymol., 6, 854-870 (1963).
25. P. D. Scotti, The estimation of virus density in isopycnic cesium chloride gradients, J. Virol. Meth., 12, 149-160 (1985).